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Cardiac troponin T is necessary for normal
development in the embryonic chick heart
Jennifer England, Kar Lai Pang, Matthew Parnall, Maria Isabel Haig and Siobhan Loughna
School of Life Sciences, Medical School, University of Nottingham, Nottingham, UK
Abstract
The heart is the first functioning organ to develop during embryogenesis. The formation of the heart is a
tightly regulated and complex process, and alterations to its development can result in congenital heart
defects. Mutations in sarcomeric proteins, such as alpha myosin heavy chain and cardiac alpha actin, have now
been associated with congenital heart defects in humans, often with atrial septal defects. However, cardiac
troponin T (cTNT encoded by gene TNNT2) has not. Using gene-specific antisense oligonucleotides, we have
investigated the role of cTNT in chick cardiogenesis. TNNT2 is expressed throughout heart development and in
the postnatal heart. TNNT2-morpholino treatment resulted in abnormal atrial septal growth and a reduction in
the number of trabeculae in the developing primitive ventricular chamber. External analysis revealed the
development of diverticula from the ventricular myocardial wall which showed no evidence of fibrosis and still
retained a myocardial phenotype. Sarcomeric assembly appeared normal in these treated hearts. In humans,
congenital ventricular diverticulum is a rare condition, which has not yet been genetically associated. However,
abnormal haemodynamics is known to cause structural defects in the heart. Further, structural defects,
including atrial septal defects and congenital diverticula, have previously been associated with conduction
anomalies. Therefore, to provide mechanistic insights into the effect that cTNT knockdown has on the
developing heart, quantitative PCR was performed to determine the expression of the shear stress responsive
gene NOS3 and the conduction gene TBX3. Both genes were differentially expressed compared to controls.
Therefore, a reduction in cTNT in the developing heart results in abnormal atrial septal formation and aberrant
ventricular morphogenesis. We hypothesize that alterations to the haemodynamics, indicated by differential
NOS3 expression, causes these abnormalities in growth in cTNT knockdown hearts. In addition, the muscular
diverticula reported here suggest a novel role for mutations of structural sarcomeric proteins in the
pathogenesis of congenital cardiac diverticula. From these studies, we suggest TNNT2 is a gene worthy of
screening for those with a congenital heart defect, particularly atrial septal defects and ventricular diverticula.
Key words: atrial septal defects; cardiac troponin T; congenital cardiac diverticula; heart development;
structural protein.
Introduction
Congenital heart defects (CHDs) occur in approximately
one in 180 live births (British Heart Foundation
www.bhf.org.uk), and are a result of abnormal heart
development. Cardiogenesis is initiated early in vertebrate
development [Hamburger and Hamilton (HH) stage 10
(during day 2) in chick] (Hamburger & Hamilton, 1951).
It begins by the formation of a simple, almost symmet-
rical heart tube which beats in a peristaltic motion. This
process is made possible due to the assembly of a contrac-
tile unit, the sarcomere, which contains various structural
proteins produced by the myocardial cell population,
including myosin, actin and associated proteins tropo-
myosin and troponin (England & Loughna, 2013). As the
heart tube matures, the primitive atrium becomes divided
by the formation of a septum primum. This septum is initi-
ated from the dorsocranial atrial wall at approximately
HH14 (early day 3) and grows towards the developing
endocardial cushions in the atrioventricular canal and is
completed by HH24 (early day 5). Trabeculae appear in
the primitive ventricle at HH17 and later contribute to
ventricular septation, which is initiated by HH23 (day 4)
and is completed by HH29–30 (day 7).
Although much progress has been made in the under-
standing of the complexity of cardiogenesis and its
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contribution to CHDs, gaps in our knowledge still remain.
Several mutations in the genes of structural proteins have
now been linked to CHDs such as myosin heavy chain
(MYH) 6, MYH7 and alpha cardiac actin (Ching et al. 2005;
Budde et al. 2007; Matsson et al. 2008). Mutations in all
three of these structural proteins have been associated with
one of the most common CHDs, atrial septal defects (ASDs),
which occur in approximately one in 1500 live births. Con-
genital cardiac diverticulum, a localized protrusion of the
endocardium and myocardium commonly associated with
the left ventricular chamber of the heart that has normal
contractility, is reported to occur at a frequency of approxi-
mately 0.04% in the general population (Marijon et al.
2006; Ohlow, 2006). In contrast to ASDs, to our knowledge,
genetic mutations linked to congenital cardiac diverticula
have not been reported.
Troponin T (TNT) is a 30–35 kDa protein that binds the
troponin complex to tropomyosin and actin, serving as a
scaffold and holding the thin filaments in contact. The N-
terminus of TnT binds to tropomyosin while the C-terminus
binds to the remaining troponin complex (Heeley et al.
1987). The human TNNT2 gene, which encodes cardiac TNT
(cTNT), is located on chromosome 1 and is alternatively
spliced, leading to the creation of four different isoforms
(Mesnard et al. 1995). The differential splicing for TNNT2 is
developmentally regulated, where isoforms 1, 2 and 4 are
predominantly expressed in the human fetal heart, and iso-
form 3 (exon 5 absent) is expressed in the adult heart
(Anderson et al. 1991). Thus, some isoforms are present only
in specific stages of development. Interestingly, the fetal iso-
forms are re-expressed at the mRNA and protein level in
individuals with heart failure (Solaro et al. 1993; Anderson
et al. 1995). Cardiac troponin T mutations have been associ-
ated with cardiomyopathies in humans and are inherited as
autosomal dominant traits (Lu et al. 2013). Although muta-
tions in TNNT2may result in mild hypertrophy, they can also
cause sudden cardiac death (Watkins et al. 1995; Lu et al.
2013). Currently, over 100 mutations have been identified in
troponin subunits associated with hypertrophic, dilated and
restrictive cardiomyopathies, with over 50 of those found in
cardiac troponin T (Lu et al. 2013). However, to date, TNNT2
has not been linked to CHDs.
Targeted manipulation of Tnnt2 prior to heart develop-
ment in the mouse, axolotl and zebrafish has been studied.
The homozygous null mouse (Tnnt2–/–) was not viable
beyond embryonic day (E)10.5 with no contractile activity
observed, consistent with a lack of sarcomeric organisation
(Ahmad et al. 2008). Disorganized myofibrils were also seen
in the Mexican axolotl mutant heart (gene c mutant) (Fran-
sen & Lemanski, 1989). Morpholino knockdown of cTnt in
the zebrafish did not affect the formation of Z-bodies, the
initial structure for myofibrillogenesis; however, the
Z-bodies never assembled further into pre-myofibrils
(Huang et al. 2009). Thus, Tnnt2 is thought to play a key
role in myofibrillogenesis.
Here we confirm and describe the expression of TNNT2 iso-
forms in the chick heart at different developmental ages. In
this study, targeted knockdown of cTNT in the chick was per-
formed at HH11, after the heart tube has formed. TNNT2-
morpholino (TNNT2-MO) treatment at this stage led to the
development of diverticula in the primitive ventricular wall.
Furthermore, the size of the atrial septa and the number of
ventricular trabeculae were reduced, although abnormalities
in sarcomeric assembly and maturation were not seen
in vitro. Quantitative PCR (qPCR) revealed that TNNT2-MO
treatment during cardiogenesis results in changes to the
cardiac conduction transcription factor TBX3. In addition, the
shear stress responsive gene nitric oxide synthase 3 (NOS3)
was differentially expressed in the TNNT2-MO-treated hearts.
We provide evidence of novel roles for TNNT2 in heart devel-
opment, and suggest it as a candidate gene for CHDs, in par-
ticular ASDs and congenital cardiac diverticula.
Methods
Tissue collection
White fertile chicken eggs (Gallus gallus; Dekalb White strain; Henry
Stewart, UK) were incubated at 38 °C in a humidified atmosphere
with constant rotation prior to opening (Bellairs & Osmond, 2005).
The Hamburger and Hamilton (HH) staging system was used to age
developing chicks (Hamburger & Hamilton, 1992) and once the
incubation time was complete, a small window was made in the
egg. For RNA isolation, the hearts were immediately dissected and
snap frozen in liquid nitrogen prior to storage at 80 °C. For
TNNT2-MO treatment, 3–5 mL of albumin was removed with a syr-
inge to separate the embryo from overlying membranes. After
treatment, the eggs were sealed with masking tape and placed
back in the incubator until harvesting.
RNA isolation and RT-PCR
RNA was extracted from chick HH12, 14, 19, 22, 24, 26 and 34 hearts,
neonatal (day 1) and adult atria and ventricles as previously described
(Rutland et al. 2011). Reverse transcription reactions were performed
using 1 lg RNA and random primers with SuperScript III Reverse Tran-
scriptase (Invitrogen, UK) followingmanufacturer’s instructions. A pri-
mer pair was designed to chick TNNT2 in the region where alternate
splicing occurs (exon 5), giving rise to both fetal and adult isoforms of
TNNT2 (forward 50CGGACTCTGAAGAGGTCGTT30 and reverse
50TTGGGCTTTGATTCACCTTC30). GoTaq polymerase was used (Pro-
mega, UK). The PCR reaction was carried out 58 °C and 72 °C for
annealing and extension for 33 cycles, respectively. PCR products
were resolved on a 2.5% agarose gel and were visualized under UV
light using GeneGenius Bioimaging System (Syngene, UK). PCR prod-
ucts were sequenced as previously described (Rutland et al. 2011).
Morpholino design and application
Two antisense oligonucleotides morpholinos were designed against
the TNNT2 ATG start site and to a non-overlapping upstream region
(ENSGALT00000000401; morpholino 1: 50 ACGACCTCTTCAGAGTC
CGACATGC30 and morpholino 2: 50TGGCTATCTAGCAGAACGCAAG
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GCA30). In addition, a standard control (SC) morpholino was
designed to mutated human b-globin (50CCTCTTACCTCAGTT
ACAATTTATA30; GeneTools LLC, USA). Morpholinos were tagged
with fluorescein to detect uptake by the embryo. A BLASTN search
of each morpholino showed 100% homology of the morpholino
nucleotides only to the gene of interest with E-values close to zero.
Untreated controls (UT) were also included, in which the embryos
underwent the same treatment as the experimental and SC groups,
except morpholino/pluronic gel mix was not applied. TNNT2-MO
treatment was conducted at stage HH11 (approximately 47–50 h
after incubation; heart undergoing dextral rotation and the embryo
has 13 somite pairs). Morpholino was resuspended in Hanks’
Balanced Salt Solution (HBSS) to give a final concentration of 15%
F127 pluronic gel (BASF Corp., Germany) and either 250 or 500 lM
morpholino was applied to embryos. The eggs were reincubated
until they reached HH19 (75–80 h; unpigmented eyes, straight trunk
and upper limbs extending across six somites). Animal work was
completed within national (UK home office) and institutional regu-
lations and ethical guidelines. Embryos were isolated at HH19 and
morpholino uptake was confirmed by the fluorescein tag within
the embryonic tissue using a SV11 stereomicroscope (Zeiss,
Germany). Fluorescein positive embryos were collected along with
UT controls. Embryos collected for the phenotypic and immunohis-
tochemistry studies were placed in 4% paraformaldehyde (PFA),
and embryos isolated for Western blot were snap-frozen in liquid
nitrogen and stored at 80 °C.
Western blot
Individual hearts (TNNT2-MO-treated, SC and UT) were lysed in 60 lL
10 mM Tris/EDTA buffer containing protease inhibitors. 15 lL of 69
loading buffer was added and samples were heated to 95 °C for
5 min. Samples were resolved by SDS-PAGE in a 4–12% precast gel
(Bio-Rad, UK) along with Precision Plus Protein Dual Colour Standards
(Bio-Rad). Gels were transferred onto nitrocellulose membrane. Mem-
branes were blocked in 10% bovine serum albumin (BSA) TBST for
1 h at room temperature (RT), followed by overnight incubation with
CT3 anti-mouse antibody (1 : 10 dilution; DSHB) at 4 °C. As a loading
control, blots were incubated with 1 : 2000 rabbit polyclonal GAPDH
(Abcam, UK) for 1 h at RT. Secondary antibodies were incubated for
1 h at 37 °C at 1 : 10 000 dilutions (IRDye 800CW Goat anti-rabbit
and 680RD Goat anti-mouse secondary antibodies; LI-COR, USA).
Antibody detection was completed using the Odyssey Infrared Imag-
ing System (LI-COR). All immunoblots contained TNNT2-MO-treated
(otherwise called cTNT knockdown hearts), SC and UT samples, and
the Western was carried out four times. Fluorescent intensities of the
bands were gathered for statistical analysis.
Phenotypic analysis
Embryos positive for morpholino uptake and UT controls were
externally examined at the time of harvesting. The overall structure
and size of the heart were observed as well as the embryo as a
whole. Images were taken using Stemi SV11 stereomicroscope and
camera (Zeiss). Embryos harvested and externally analysed were
fixed at room temperature (RT) in 4% PFA in phosphate-buffered
saline (PBS) for 1.5 h, washed and stored in PBS overnight. Embryos
were washed with H2O and dehydrated in 70–100% series of etha-
nol, cleared with xylene and embedded in paraffin wax in a trans-
verse orientation. Each embryo was sectioned transversely (cranial
to caudal) at 8 lm using a DSC1 microtome (Leica, Germany).
Sections were dewaxed in xylene, rehydrated in a graded ethanol
series, and stained with nuclear stain Mayer’s haemalum (Fisher
Scientific, UK). Internal features such as atrial septa, endocardial
cushions, cardiac jelly and ventricular trabeculae were examined.
Analysis was performed blind using a Nikon Eclipse microscope
(Nikon Instruments Inc., UK).
Histological and immunohistochemical analysis of
morpholino-treated hearts with diverticula
HH11/19 TNNT2-MO-treated hearts were isolated and processed for
wax embedding as described above. Embryos with diverticula were
serially sectioned at 6 lm sagittally, dewaxed and rehydrated in
graded ethanol series and water, with neighbouring sections placed
on adjacent slides to allow for the analysis of different stains. For
the histological study, one set of sections were stained with extra-
cellular matrix glycosaminoglycan Alcian Blue for 15 min at RT
followed by Mayer’s haemalum.
For the fluorescence immunohistochemistry, antigen retrieval was
performed (microwaving for 15 min in 10 mM citric acid buffer pH
6.0) on a second set of sections, and blocked in 5% pre-immune
goat serum in 1% BSA/PBS for 30 min at RT. Primary antibody,
A4.1025 (a marker for sarcomeric myosin heavy chain; 1 : 10; DSHB,
USA) was diluted in 1% BSA/PBS and incubated for 1 h at RT. Sec-
tions were incubated with secondary antibody Cy2 (1 : 100;
A4.1025; Jackson ImmunoResearch Inc., USA) for 30 min at RT.
Nuclei were stained with DAPI (4’,6-diamidino-2-phenylindole;
1 : 1000; Sigma) and imaging was carried out on a LSM5 Exciter con-
focal microscope (Zeiss).
For the Masson’s Trichrome stain, a third set of sections from the
TNNT2-MO-treated embryonic hearts with diverticula were mor-
danted in Bouin’s fixative for 1 h at 56 °C. They were then stained
with nuclei stain Weigert’s iron haematoxylin working solution for
8 min, Biebrich scarlet-acid fuchsin for muscle stain for 5 min, phos-
photungstic-phosphomolybdic acid for 12 min, and aniline blue
solution for collagen stain for 5 min. Sections were differentiated
in 1% acetic acid followed by dehydration. Images were taken
using an Axioplan microscope (Zeiss).
Stereological systematic random sampling of
morpholino treated embryos
Systematic random sampling was used to quantify cardiac tissue
proportions (HH11/19). Three groups were analysed: untreated con-
trols (UT; n = 3), standard controls (SC; n = 4) and TNNT2-MO-trea-
ted hearts (n = 9). A 96-point grid was placed over every third
section throughout the heart, and the tissue region and type on
each point were identified (7900 points counted). Tissue regions
consisted of the atrium, ventricle and OFT, with the boundaries
between the compartments defined by changes to myocardial and
cardiac jelly thickness. The tissue types counted included myocardial
wall, extracellular matrix and lumen in each of the regions men-
tioned. The average tissue proportions were calculated and tested
for statistical significance.
Isolation of cell micromass from embryonic chick
hearts and morpholino treatment
White fertile chicken eggs were incubated for 5 days (HH26; three
digits in lower limb; elbows defined in the upper limb, with longer,
rounded limb buds) as described above. Eggs were washed with tri-
gene, swabbed with IMS and placed in a clean and sterilized class II
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Laminar flow hood. The embryos were isolated in 1 : 1 horse serum/
HBSS on ice. Once explanted, the hearts were washed in HBSS and
placed in trypsin/EDTA (0.05%) at 37 °C, 5% CO2 for 20 min. The
hearts were triturated until homogenized and 8 mL of culturemedia
(10% heat inactivated fetal bovine serum, 2 mM L-glutamine and
50 units mL1 penicillin/50 lg mL1 streptomycin was added to
500 mL Dulbecco’s modified Eagle’s medium and nutrient mixture F-
12 HAM) was added. The suspension was centrifuged and the pellet
resuspended in 2 mL of warm culturemedia. The cell suspensionwas
seeded in a 24-well plate containing glass coverslips at a cell density
of 6 9 105 cells mL1. The cells were left in the CO2 incubator for 2 h
to allow attachment to the coverslips before adding 500 lL of warm
culture medium. TNNT2-MOwas pre-heated to 65 °C for 5 min. 3 lL
of Endo-Porter (GeneTools) was added to 250 lL of pre-warmed cul-
ture medium and 10 mM morpholino. SC morpholino and no treat-
ment were used as controls. The morpholino mix was added to
250 lL of culture medium in each well. Cells were left for 48 h in a
CO2 incubator.
Immunofluorescent staining and analysis of TNNT2
treatment in culture
After 48 h, the culture media was removed, cells were fixed for
10 min in 4% PFA at RT and permeabilized with 0.2% Triton-X 100
in PBS. CH1 mouse monoclonal antibody (anti-tropomyosin anti-
body; DSHB, USA) was prepared at a 1 : 50 dilution in 1% BSA in
PBS and incubated with the cells overnight at 4 °C. The cells were
rinsed with PBS and goat anti-mouse secondary antibody, Alexa
Fluor 596 (1 : 1500; Thermo Fisher Scientific Inc., UK) was incubated
with the cells for 40 min at RT. Cells were mounted on glass slides
(GeneTex, USA) and stored at 4 °C. Cells were visualized using the
DMIRE2 inverted microscope (Leica) and cells positive for CH1 anti-
body were considered cardiomyocytes. Cardiomyocytes positive for
morpholino uptake were included in the study. The assembly of the
sarcomere was divided into four stages, according to the degree of
myofibrillogenesis. Over 530 cells were analyzed for this study.
Quantitative PCR
HH19 hearts were dissected from TNNT2-MO-treated and control
embryos. Total RNA of individual hearts was extracted using Nor-
gen Total RNA Purification Kit (Norgen Biotek) according to the
manufacturer’s protocol. RNA was finally eluted from the columns
with 50 lL of RNase-free water. The concentration and purity of
the eluted RNA samples were determined using the NanoDrop
2000 c UV/IV spectrophotometer at 260 nm absorbance (Thermo
Fisher Scientific). RNA samples were stored at 80 °C. Synthesis of
cDNA template was performed using 1 lg RNA and random primers
with SuperScript II Reverse Transcriptase (Invitrogen, UK). Each
cDNA sample was diluted 4.59 with RNase-free water before the
determination of the dynamic range of sample concentrations for
the qPCR experiment. From the standard curve obtained, a concen-
tration was chosen for relative quantitation that fell in the middle
of the slope. Efficiencies of all gene reactions were between 93 and
108%, with r2-values > 0.998. qPCR was performed using the
Applied Biosystems 7500 Fast Real-time PCR system under the fol-
lowing thermal cycling conditions: a single heat-denaturing step at
95 °C for 10 min, followed by 40 cycles of annealing and extension
at 95 °C for 20 s and 62 °C for 1 min. A melt curve analysis was
performed from 50 to 95 °C, with no off-target products detected.
All samples were run in triplicate within each PCR experiment. Each
20 lL PCR reaction mixture consisted of 10 lL of iTaqTM universal
SYBR Green supermix (19), 0.5 lL of each forward and reverse pri-
mer (250 nM) for all genes and 2 lL of diluted cDNA template (1 in
11 dilution for TBX3 and 1 in 6 dilution for NOS3). Relative gene
expression was quantified with GAPDH as the reference gene. The
following primer sequences, spanning an intron, were used for
qPCR: NOS3 (GenBank accession number XM_003640632.2),
50ACCTACCAGAGCGAGAACGG30 and 50CTGCCAGAAGCTGCGGAAT
G30 (198 bp); TBX3 (NM_001270878.1), 50AGTGCACCTGGAAGCCA
AAGA30 and 50GTCGTCAGCCGCCACAATATC30 (169 bp) and GAPDH
(NM_204305.1), 50AGACGGTGGATGGCCCCTCT30 and 50ACGGCAGG
TCAGGTCAACAACA30 (263 bp).
Statistics
Levene’s test for equality of variances was completed, followed by a
t-test for equality of means on SPSS V21.0 (SPSS Inc., USA), P < 0.05
was considered as significant. Where appropriate, the mean  stan-
dard error of the mean (SEM) was calculated.
Results
Differential expression of TNNT2 isoforms in the
chick heart
To examine the differential expression of TNNT2 in the
chick heart, a gene-specific primer pair was designed
around exon 5 (present in embryonic forms of TNNT2 but
absent in the adult). cDNA was obtained from HH12, HH14,
HH19, HH22, HH24, HH26 and HH34 hearts and from
neonatal and adult atrium and ventricles. During embryonic
stages of development, an intense 235 bp band is present,
with a faint expression of a 178 bp band below (Fig. 1A). In
the neonatal and adult atrium and ventricle, there appears
to be a shift in expression, as expected, with the upper
band becoming less intense and the lower band intensely
expressed at 178 bp (Fig. 1B). The upper 235-bp band con-
tains exon 5, whereas the lower band is formed by alternate
splicing omitting exon 5 from the RNA sequence. Glycer-
aldehyde 3-phosphate dehydrogenase (GAPDH) was uti-
lized as a loading control (Fig. 1A,B).
Embryo grouping, survival and TNNT2-MO uptake
Two concentrations of TNNT2-MO, 250 and 500 lM, were
initially used to determine the optimal concentration.
HH11/19 represents morpholino treatment at HH11, and
harvesting at HH19. For the 250 lM study, the survival rates
for untreated (UT) chick embryos (n = 22), standard control
(SC) group (n = 30) and TNNT2-treated (n = 43) embryos
were 90.9, 94.1 and 91.5%, respectively (P > 0.298). Survival
rates for the 500-lM study for UT (n = 52), SC (n = 56) and
TNNT2-MO-treated group (n = 106) were 96.1, 91.7 and
92.9%, respectively (P > 0.275). Surviving embryos were
examined for ‘morpholino uptake’ determined by the
degree of fluorescence (Fig. 2A). In the 250-lM study, 43.8%
of the SC and 58.1% of the TNNT2-MO-treated embryos
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were positive for morpholino uptake (P = 0.448). For the
500-lM study, 63.6% of the SC and 73.6% of the TNNT2-
MO-treated embryos were positive (P = 0.446).
TNNT2-MO treatment results in decreased cTNT in
the heart
Western blot analysis was used to quantify the degree of
protein ‘knockdown’ in individual hearts treated with
TNNT2 ATG start-site morpholino. CT3 antibody detecting
cTNT was normalized using GAPDH. No significant differ-
ence between the UT and SC groups (n = 3) was seen
(P = 0.233) and these two groups were therefore pooled
into one control group. When the control and TNNT2-trea-
ted hearts (n = 5) were compared, TNNT2 was significantly
decreased in the TNNT2-treated hearts and knockdown was
achieved (P = 0.016; Fig. 2B,C).
TNNT2-MO treatment results in the development of
a diverticulum in the ventricular wall
Once embryos were confirmed positive for morpholino
uptake, embryos were phenotypically examined. External
features such as looping; atrial and ventricular positioning
and size; length and shape of the outflow tract (OFT)
were studied. No external phenotype was observed for
the 250-lM study for either the controls (n = 34) or TNNT2-
MO-treated (n = 43) embryos (see Table 1 for a summary
of TNNT2-MO experiments). For the 500-lM study, all con-
trols (n = 84) and the majority of TNNT2-MO-treated
embryos (n = 67) appeared to have a normal external
phenotype (Fig. 2Da,b‘). However, two of the TNNT2-MO-
treated hearts presented with a diverticulum on the heart
wall. Both diverticula were situated at the anterior part of
the primitive ventricle, with one present inferior to the
OFT (diverticulum 1; Fig. 2Dc,c‘) and one inferior to the
atrium (diverticulum 2; Fig. 2Dd-e‘).
Normal morphology and histology of the novel
diverticulum on TNNT2-MO-treated embryonic hearts
To further investigate the ventricular diverticula, both
hearts were sectioned serially, and consecutive sections col-
lected on adjacent slides to allow for analyses with different
markers. A set of these sections were Alcian blue- and hae-
malum-stained. The first diverticulum appeared as a mild
protuberance of the myocardium and endocardium located
just inferior to the OFT, on the anterior part of the right
side of the primitive ventricle. The second diverticulum
appeared to have a more complex structure compared to
the first diverticulum. Fig. 2E compares a control heart with
a normal gross morphology with the second diverticulum,
both sectioned sagitally. The control heart shows the struc-
ture of a normal heart progressing through the ventricle
and atrium (Fig. 2Ea-j). In the images for the second diver-
ticulum, we first saw the appearance of the diverticulum on
the anterior part of the left side of the primitive ventricle
inferior to the primitive atrium (arrow in Fig. 2Ea‘). As the
sections progress through the ventricular chamber, a com-
munication appears between the ventricle and the divertic-
ulum (Fig. 2Eb‘). This communication quickly closes
(Fig. 2Ec‘-e‘). Towards the end of the ventricular chamber,
Fig. 1 mRNA expression of TNNT2 in the
embryonic, neonatal and adult chick heart.
PCR products obtained using a primer pair
designed around the exon 5, which is
alternately spliced in TNNT2. (A) Expression of
a TNNT2 isoform in the embryonic chick heart
(HH12–34; 235 bp). A smaller band of
178 bp can also be seen faintly expressed.
GAPDH was used as a loading control
(500 bp). (B) Two bands can be clearly seen
in both the atrium and ventricle of the
neonatal heart. In the adult atrium and
ventricle, however, the lower band has a
stronger signal than the upper 235 bp band.
GAPDH was used as a loading control. +
indicates RT; , noRT; bp, base pairs; H2O,
PCR control.
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as the atrioventricular canal and atrial chamber appears,
another communication can be seen (Fig. 2Ef‘). Again, the
communication closes (Fig. 2Eg‘-h‘) until the diverticulum
reopens for the final time in the atrial chamber (Fig. 2Ei‘-j‘).
To investigate whether the diverticula were of the muscu-
lar or fibrous type, Masson’s trichrome staining was also
completed on a third set of neighbouring sections to detect
excess collagen deposits within the diverticula. This staining
technique revealed no abnormal collagen deposits within
the diverticula indicating a non-fibrous phenotype
(Fig. 3Ab,b‘) in comparison with control heart (Fig. 3Aa,a‘).
To complement this data, anti-myosin antibody staining
was performed on a third set of neighbouring sections to
detect muscle fibres within the hearts with diverticula.
When compared with a control heart (Fig. 3Ba,a‘), the mus-
cle fibres appeared normal in the myocardium of both
diverticula (Fig. 3Bb-c‘).
TNNT2-MO treatment results in abnormal atrial septa
formation
HH11/19 embryos were serially sectioned in a transverse
orientation to investigate the development of the atrial
septum from the dorsocranial wall of the common atrium.
For the 250-lM study, normal atrial septation was present in
all control (n = 15) and TNNT2-MO-treated groups (n = 19),
with all septa appearing to have a normal size (Table 1). In
the 500-lM study, the atrial septa appear to develop nor-
mally in all but one of the controls (n = 37; Table 1;
Fig. 4Aa,b,a‘). In the TNNT2-MO-treated embryos, atrial sep-
tation was induced in all hearts. However, in 45% of these
TNNT2-MO hearts, the septum appeared small and resem-
bled a knuckle-shaped outgrowth from the atrial myocar-
dium (n = 23/51; Table 1; Fig. 4Ac,d,c‘). This includes the
two hearts with the diverticula (see arrowhead in Fig. 2Ei‘;
control Fig. 2Ef,g).
Trabeculation of the ventricular myocardium is
affected in a subset of the hearts with an abnormal
atrial septum
Normal development of the ventricular myocardium was
also assessed in the TNNT2-MO-treated embryos. Trabecu-
lae, finger-like muscular projections when sectioned trans-
versely, appear normal in the UT and SC groups in both the
500-lM and 250-lM studies (n = 15 and n = 38, respectively;
Table 1; Fig. 4Aa,b,a‘‘) and appeared normal for all of the
250-lM TNNT2-MO-treated group (n = 19). In the 500-lM
study, almost all embryos appear to have normal trabecula-
tion (Fig. 4Ac); however, a small proportion (11.8%) of the
hearts appeared to have a reduced number and size of tra-
beculae (6/51; Fig. 4Ac,c‘‘). Interestingly, all the hearts
Table 1 Summary of phenotypic analysis after treatment with TNNT2 morpholino.
Concentration
of morpholino
Embryo
type*
External heart shape
Internal heart structures
Total
internal
Atrial septum Trabeculation
Diverticulum
present Normal
Total
external Reduced Normal Reduced Normal
500 lM Control – 84 84 1 37 – 38 38
TNNT2 2** 65 67 23 28 6 45 51
250 lM Control – 34 34 – 15 – 15 15
TNNT2 – 43 43 – 19 – 19 19
Assessment of heart shape based on qualitative analysis of gross morphological features.
Qualitative assessment of atrial septa and degree of trabeculation obtained from serial histological sections.
TNNT2 denotes embryos treated with the TNNT2 ATG start site morpholinos.
*Control embryos include standard and untreated controls.
**Both embryos with diverticula had reduced atrial septal size.
Fig. 2 TNNT2-MO treatment results in a knockdown of cTNT and external analysis reveals diverticula protruding from the heart wall. (A) Embryos
were treated at HH11 with a TNNT2 or standard control fluorescein-tagged morpholino; only embryos showing a strong fluorescent signal were
harvested (at HH19). (b,d) Fluorescent embryo in comparison to brightfield a,c; both left- (a,b) and right-hand side (c,d) shown. (B,C) Western blot
of individual hearts treated with either TNNT2-MO, standard control morpholino or untreated at HH11 results in a significant decrease of cTNT at
HH19 (P = 0.016). On (B) the lanes 1–3 are untreated, 4–6 have had standard morpholino applied, and 7–11 are TNNT2-MO-treated. (D) External
analysis of embryos treated with TNNT2-MO reveals normal heart development in the majority of embryos (b and b‘) when compared with the
controls (a and a‘). However, two embryos presented with diverticula on the heart wall (c and c‘, d and d‘). Diverticulum 2 is shown at higher
magnification (e and e‘). (E) Serial sectioning through a control (a-j) and embryo with diverticulum 2 (a‘-j‘). Three opening are present between the
ventricular chamber into the diverticulum (b‘, f‘and i‘). Arrowheads denote the normal atrial septa in controls (f and G), which is reduced in diver-
ticulum 2 heart (i‘). *, outflow tract; arrowhead, atrial septum; arrows, diverticulum; at, atrium; LHS, left-hand side of embryo; RHS, right-hand
side of embryo; v, ventricle; Scale bars: 100 lm.
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displaying reduced ventricular trabeculae also had a
reduced atrial septum.
Stereological analysis reveals reduced atrial chamber
size but normal tissue proportions throughout the
heart
Stereological analysis was completed on TNNT2-MO-treated
embryos to obtain information regarding tissue proportions
compared with control hearts. For the control hearts (UT
n = 3; SC n = 4) 3978 points were counted, and for the
TNNT2-MO-treated hearts, 3922 points were counted
(n = 9). A percentage proportion of the atrium, ventricle
and OFT was first achieved by dividing the total number of
counts per region by the total number of counts for that
heart (Fig. 4B). No significant difference was seen between
the UT and SC groups (P > 0.598) and the two groups were
therefore pooled. Upon comparing the total proportion the
atrium contributed to the heart size, the atrium in the
TNNT2-MO-treated hearts was smaller than in the controls
(22.32  0.53 and 24.85  1.12%, respectively; 0.045 lM ;
Fig. 4B). No significant difference in proportions was seen
in the OFT and ventricle between the control and knock-
down hearts (Fig. 4B; P > 0.053). The percentage of lumen,
myocardium and ECM within each heart region (OFT, ven-
tricle and atrium) was also analyzed using this stereological
method. As no significant difference was seen between the
UT and SC groups, they were pooled (P > 0.091). No differ-
ences were seen in any of the heart regions between the
controls and the TNNT2-MO-treated hearts (Fig. 4C;
P > 0.120).
TNNT2-MO treatment in culture does not result in
aberrant sarcomere assembly
The effect of TNNT2-MO treatment on sarcomere assembly
was investigated using cardiac cell micromass. Over 500 car-
diomyocytes that showed uptake of the fluorescein-tagged
morpholino were analysed in four independent studies.
Using an anti-TPM1 antibody to detect the sarcomere, we
classified each cardiomyocyte into one of four stages
depending on its sarcomeric maturity. Stage 1 consisted of
cells with positive staining around the periphery of the cell
but no sarcomeric structures can be clearly seen, especially
around the nucleus (Fig. 5Aa). Stage 2 cardiomyocytes con-
tain assembled sarcomeres; however, they appear thin and
disorganized (Fig. 5Ab). Stage 3 cardiomyocytes present
with organized sarcomeres that appear thin but are
A
B
a b c
a′ b′ c′
a
c
a′
b b′
Fig. 3 Histological analysis of the diverticula
in the TNNT2-MO-treated embryos. (A)
Masson’s Trichrome staining was used to
detect collagen that may have been
deposited due to fibrosis of the heart. When
compared with a control heart (a and a‘), the
diverticula did not appear to show a
noticeable change in collagen deposition that
would be indicated by the black/blue staining
(b and b‘). Chick skin was used as a control
for the Trichrome stain (c). Scale bars: (a,a‘)
300 lm. (B) An anti-myosin heavy chain
antibody was used to detect cardiac muscle
in the heart. When compared with the
control (a), diverticulum 1 and 2 had normal
cardiac muscle appearance, with the presence
of mature myofibrils in the myocardial wall
(arrows; b and c). a‘, b‘ and c‘ show
sarcomeres at higher magnification from
images a, b and c, respectively. Scale
bar: 80 lm.
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organized and run parallel to one-another (Fig. 5Ac).
Finally, stage 4 cardiomyocytes contain mature cardiomy-
ocytes with thick bands running through the cell (Fig. 5
Ad). As no significant difference was seen between UT and
SC-treated cells these data were pooled (P > 0.582). When
the control group was compared with the TNNT2-MO-trea-
ted group, no significant difference was seen in sarcomere
assembly in any of the groups (P > 0.180).
TNNT2-MO treatment alters the expression of NOS3,
a shear stress marker, within the embryonic heart
During heart development, normal haemodynamics is
important for normal development, and blood flow corre-
lates with the shear stress placed upon the heart. NOS3 is a
shear stress-responsive gene, and known to be essential for
atrial septation (Feng et al. 2002; Groenendijk et al. 2005;
Liu & Feng, 2012). Therefore, to investigate the potential
cause of the abnormal atrial septum and reduced trabecu-
lae in the TNNT2-MO-treated hearts, NOS3 expression was
quantitatively analysed. qPCR was conducted using 10 indi-
vidual TNNT2-MO-treated embryonic hearts to evaluate a
trend in expression after morpholino treatment. As no sig-
nificant difference in expression was identified between
the controls, they were pooled (n = 3). Of the 10 TNNT2-
MO-treated hearts, the expression of NOS3 was elevated in
three (30%; hearts 1, 2 and 8; Fig. 6A). Within these hearts,
there was a 2.57-, 1.96- and 2.02-fold increase of NOS3,
respectively. Conversely, heart 10 had a 2.08-fold decrease
in NOS3 expression, whereas the remaining six hearts
appeared to have no change in NOS3 expression compared
with controls (60%; hearts 3, 4, 5, 6, 7 and 9).
TNNT2-MO treatment during heart development
alters TBX3 expression, a marker of the developing
conduction system
Previous studies have associated structural proteins with
abnormal electrical activation of the heart and with sinus
node dysfunction (Holm et al. 2011; Rutland et al. 2011).
A
a
a′ a′′
b c
c′ c′′
d
B C
Fig. 4 TNNT2-treated embryos undergo abnormal atrial septation and trabecular formation, and the atrial chamber is reduced in size. (A) Internal
analysis of the UT and SC hearts revealed normal structures (a, b), with initiation and growth of an atrial septum (a‘) and trabeculae (a‘‘). In con-
trast, although TNNT2-treated hearts displayed atrial septation initiation, the atrial septum in these hearts appeared small in size (c,c‘,d). In the ven-
tricles, the trabeculae of a subset of the atrial phenotypic hearts were reduced in size and numbers (c,c‘‘). (B) Upon stereological analysis, the atrial
contributions to the total heart size was decreased in TNNT2-treated hearts; this decrease appeared small but was statistically significant
(P = 0.045), whereas the OFT and ventricular contributions to heart size remained the same (P > 0.053). (C) No difference in tissue proportions
contributing to each region of the heart was seen upon stereological analysis (P > 0.120). *, trabeculae; arrow, septum; at, atrium; v, ventricle.
Scale bars: 100 lm.
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Using TBX3 as a marker for the maturing conduction sys-
tem, quantification of TBX3 expression was analysed in
individual TNNT2-MO-treated hearts. Again, no significant
difference was seen between three SC morpholino-treated
hearts and they were pooled as a control. Seven of the 10
TNNT2-MO hearts appeared to have normal expression
when compared with the control (hearts 1, 3, 4, 7, 8, 9
and 10; Fig. 6B). Interestingly, 30% of the hearts had
reduced expression of TBX3 (hearts 2, 5 and 6, showing a
1.54-, 1.5- and 1.88-fold down regulation, respectively;
Fig. 6B).
Discussion
cTNT is a vital sarcomeric protein expressed in the develop-
ing chick heart. As shown in this study, TNNT2 isoforms are
expressed as early as HH12 in the developing chick heart
and are present throughout development. Using RT-PCR
and knowledge of TNNT2 alternate splicing, we have
shown that the fetal isoforms are predominantly expressed
in the developing embryonic heart (Fig. 1). In the neonatal
heart, there appears to be an isoformal shift occurring,
where both fetal and adult isoforms are detected. In the
adult heart, the fetal isoform appears decreased with the
predominant expression of the adult isoform (which does
not contain exon 5).
Targeted manipulation of cTNT in ovo using morpholinos
results in the development of a diverticulum from the wall
of the primitive ventricle. According to the literature, diver-
ticula are early embryological defects that usually arise from
the left ventricle apex as a congenital left ventricular diver-
ticulum, although many cases of right ventricular and both
atrial diverticula have been reported (Binder et al. 2000;
Caldaroni et al. 2014; Ohlow et al. 2015). Ventricular diver-
ticula can be either muscular or fibrous, and they may or
may not be associated with other CHDs, such as ASDs, ven-
tricular septal defects, persistent ductus arteriosus, coarcta-
tion of aorta and conduction defects (Villegas Garcia et al.
2001; Pitol et al. 2005; Di Sessa et al. 2006; Ohlow, 2006;
Ohlow et al. 2015). Although ventricular diverticula can
remain asymptomatic, congestive heart failure, systemic
embolism and sudden cardiac death may occur. Congenital
ventricular diverticula have also on occasion been associ-
ated with hypertrophic cardiomyopathy (Maron et al.
1996). However, our embryonic hearts appeared to have a
normal size and did not appear enlarged, although muta-
tions in TNNT2 have been associated with cardiomyopathy
in the literature (Watkins et al. 1995).
A
B
a b c d
Fig. 5 TNNT2-MO treatment does not result in aberrant myofibrillogenesis. (A) An example of non-treated cardiomyocytes in culture. Sarcomere
assembly was categorized into four types: type 1 is the immature myofibril which is assembling at the periphery of the cell and no fibril structures
can be seen (a); type 2 is when fibres are present but in a disorganized fashion (b); type 3 has organized but still thin fibrils (c); type 4 has fully
developed thick fibrils running from one end of the cell to the other (d). Arrows indicate the direction of the myofilaments. Scale bar: 80 lm.
(B) TNNT2-MO treatment does not appear to affect sarcomere assembly and maturity (P > 0.180).
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One of the diverticula observed in our study (diverticulum
2; Fig. 2Dd,d‘) had similar morphology observed to the
diverticulum seen in humans. Based on the phenotypic
analysis, the ‘outpouching’ was connected to the primitive
ventricle, atrioventricular canal and atrium through narrow
communications (Fig. 2E), and had systolic contractility that
was synchronous with the ventricle. Diverticulum 1 in this
study had a different morphology in that it did not appear
as an extra chamber and appeared more similar to a mild
protuberance from the myocardial wall (Fig. 2Dc,c‘). In
addition, Masson’s trichrome stain did not reveal fibrosis in
the myocardium of the diverticula. Furthermore, an anti-
myosin antibody revealed normal sarcomeric structures in
the myocardium, indicating that the diverticula presented
here are of the muscular type. In the literature, the muscu-
lar type of cardiac diverticulum is often localized on the
inferior or anterior walls of the left ventricle at the apex
(Ohlow et al. 2015). In our case, we found our diverticulum
1 and diverticulum 2 were localized on the anterior part of
the primitive ventricle inferior to the OFT and primitive
atrium, respectively but not at the apex. Also, it has been
proposed that the cardiac diverticulum is a developmental
defect that potentially forms as a result of the structural
muscle weakness of the heart (Lowe et al. 1959; Ohlow,
2006). Here, we postulate that the reduction of cTnT pro-
tein leads to muscular weakness and thus formation of the
diverticulum. To our knowledge, this is the first report link-
ing knockdown of sarcomeric proteins to diverticula. This
diverticula phenotype was never present in any of the con-
trols or, in fact, in any other morpholino experiments con-
ducted by us or other laboratories targeting different
sarcomeric genes (Ching et al. 2005; Matsson et al. 2008;
Rutland et al. 2009, 2011). Although the phenotype was
infrequent, it is believed that left ventricular diverticulum
occur in only 0.04% of the general population. Interest-
ingly, the literature reports the co-existence of muscular
congenital cardiac diverticula with ASDs (Walton-Shirley
et al. 1992; Shahmohammadi et al. 2008; Ohlow et al.
2015); in this study, in both of the hearts with a diverticu-
lum, a reduced atrial septum was also found.
Stereological investigation did reveal that upon TNNT2-
MO treatment, the proportion of the atrium relative to the
remaining heart was smaller than that of the control hearts
(Fig. 4B). It is unknown whether this reduction in size is due
to underdevelopment of the chamber itself, or caused by
some haemodynamic changes through the atrial chamber.
In addition, TNNT2-MO treatment at the early stages of car-
diogenesis results in abnormal septal growth in 45% of
treated hearts. The septa appeared as knuckle-shaped out-
growths from the dorsocranial atrial wall (Fig. 4A). This was
also true for the atrial septum in the hearts with diverticula
(Fig. 2D). The ventricular region of the cTNT knockdown
hearts, in general, appeared phenotypically normal. How-
ever, a subset of hearts had reduced trabeculation in the
ventricle (11.8%; Fig. 4A). During embryonic development,
normal haemodynamics is critical for the development of
structures within the heart and associated vasculature
(Hogers et al. 1999; Hove et al. 2003; Granados-Riveron &
Brook, 2012). Importantly, shear stress induces NOS3 expres-
sion during chick cardiogenesis (Groenendijk et al. 2005).
NOS3 is expressed in the atrial septum and ventricular tra-
beculae (Groenendijk et al. 2005), with chick atrial septation
initiated at approximately HH14. In the Nos3–/– mouse,
there was a high incidence of septal defects (64% ASD;
11% ventricular septal defects) (Feng et al. 2002; Liu & Feng,
2012), most likely due to an increase in apoptosis and reduc-
tion in proliferation (Lepic et al. 2006). Further, Nos3 is
known to interact with cardiac transcription factor Tbx5,
Fig. 6 TNNT2-MO treatment alters the
expression of NOS3 and TBX3 in the
developing heart. (A) NOS3 expression is
increased in hearts 1, 2 and 8 when
compared with the control. In heart 10, the
expression of NOS3 is decreased. The
expression in hearts 3, 4, 5, 6, 7 and 9
remain comparable to that in controls. (B)
TBX3 expression is decreased in hearts 2, 5
and 6 when compared with the control. The
expression of TBX3 in hearts 1, 4, 7, 8, 9 and
10 remains comparable to that in the control.
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with Tbx5 expressed in endocardial cells that will contribute
to the atrial septum (Nadeau et al. 2010). From the analysis
of genetic mutants and in vitro studies, Nos3 is predicted to
be a genetic modifier of Tbx5 in atrial septa formation
(Nadeau et al. 2010). Therefore, we looked at the expres-
sion of NOS3 in individual TNNT2-MO-treated embryonic
hearts to see if any alterations in shear stress may be occur-
ring. In our study, variable expression of NOS3 was seen in
TNNT2-MO-treated hearts by qPCR, with three hearts show-
ing increased and one heart a reduction in expression com-
pared with controls, suggesting the hearts are responding
differently to the altered blood flow. Future studies on
apoptosis and proliferation in the TNNT2-MO-treated hearts
may elucidate whether these processes contribute to the
abnormal structural phenotypes observed.
In the chick, pacemaker-like activity has been found in a
small population of progenitor cells at HH8 (Bressan et al.
2013). The transcription factor TBX3 is a marker of the devel-
oping conduction system, with expression seen in the sinoa-
trial region at E8.5/9 in the murine heart (Binder et al. 2000;
Hoogaars et al. 2004; Baruteau et al. 2015; van Weerd &
Christoffels, 2016). Analysis of a transgenic mutant at E9.5 in
the mouse showed that overexpression of Tbx3 inhibited
myocardial differentiation by suppression of chamber
genes, such as Nappa and Cx40 (Mommersteeg et al. 2007).
The Nppa promoter is known to be activated by Tbx5, an
interaction which can be prevented by Tbx3 (Hoogaars et al.
2004); Tbx5 is also known to be important in atrial septation
(Li et al. 1997). By inhibiting myocardial genes, TBX3 permits
the differentiation of the sinoatrial node, the AV bundles
and bundle branches (Hoogaars et al. 2007; Mommersteeg
et al. 2007; Bakker et al. 2008). Importantly, Tbx3 appears to
be sensitive to dosage with variable levels of under-expres-
sion as well as ectopic expression in the mouse leading to a
range of conduction anomalies, and hence has been pro-
posed as a candidate gene for arrhythmias in humans (Hoo-
gaars et al. 2007; Frank et al. 2012). In this study, qPCR of
individual TNNT2-MO-treated hearts revealed a decrease in
TBX3 expression in three of the 10 hearts examined, which
could lead to the aberrant formation of the early conduc-
tion system. Structural proteins have previously been associ-
ated with abnormal electrical activation of the heart and
with sick sinus syndrome (Holm et al. 2011; Rutland et al.
2011). Further, conduction defects have accompanied a
range of structural defects, including ASDs and congenital
cardiac diverticula (Ohlow, 2006; Baruteau et al. 2015).
Although the Tnnt2–/– mouse was not viable due to the
lack of sarcomeric organization and contractility (Ahmad
et al. 2008), we found that TNNT2-MO treatment did not
affect sarcomere assembly. In the zebrafish mutant,
Z-bodies did form; however, pre-myofibrils were not pro-
duced (Huang et al. 2009). In both the mouse and zebra-
fish models, targeted deletion of cTnT occurs prior to its
expression in the developing embryo. In contrast, with the
chick, morpholino treatment is completed at HH11, when
the heart tube is present and there is already expression
of sarcomeric proteins, including cTNT. Therefore, a pro-
tein pool of cTNT is already available to the embryo after
knockdown using the morpholino. By allowing the initial
heart tube to form prior to morpholino treatment, devel-
opmental processes such as atrial septation and matura-
tion of the ventricular chamber can be studied in this
model system, which was not possible in the Tnnt–/–
mouse, due to embryonic lethality at E10.5. In recent
years, the specificity of morpholino oligonucleotides has
come under scrutiny (Kok et al. 2015). However, many
advantages remain for the use of morpholinos and are
still useful entities when comprehensive controls are used
(Blum et al. 2015).
To our knowledge, this is the first study associating
TNNT2 to abnormal atrial septal growth, reduced ventricu-
lar trabeculation and ventricular diverticula. The altered
expression of TBX3 and NOS3 suggests that a reduction in
cTnT in the developing heart affects important molecular
signals required for normal development, and in turn
results in the abnormal gross anatomical phenotypes
observed in this study. Further investigations into haemody-
namic changes and/or altered contractility within these
hearts would be necessary to provide insights into the
effects that reduced cTnT has on these processes. Further-
more, studies need to be performed on the TNNT2 gene to
find a link between TNNT2 and CHDs in humans.
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